From: LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma
Clinical characteristics | Samples | OR (odd ratio) | p-value |
---|---|---|---|
Age (continuous) | 537 | 0.99 (0.98–1.01) | 0.214 |
Gender (female vs. male) | 537 | 0.67 (0.47–0.96) | 0.029* |
Grade (G1 vs. G4) | 520 | 0.16 (0.04–0.53) | 0.004* |
Stage (I vs. III) | 534 | 0.55 (0.36–0.85) | 0.007* |
 (I vs. IV) | 534 | 0.44 (0.26–0.72) | 0.001* |
T (T1 vs. T3) | 537 | 0.51 (0.35–0.75) | 0.001* |
 (T1 vs. T4) | 537 | 0.07 (0.00–0.39) | 0.013* |
M (M0 vs. M1) | 505 | 0.54 (0.32–0.88) | 0.015* |